Gender-specific differences in the incidence of microalbuminuria in metabolic syndrome patients after treatment with fimasartan: The K-MetS study

BACKGROUND: The effect of resolving metabolic syndrome on target organ damage in hypertensive patients is not well described. We evaluated whether treating metabolic syndrome (MetS) with an angiotensin receptor blocker subsequently reduced microalbuminuria in the K-MetS cohort. METHODS: Among 10,601...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jeong Bae, Kim, Su-A, Sung, Ki-Chul, Kim, Jang Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736217/
https://www.ncbi.nlm.nih.gov/pubmed/29261715
http://dx.doi.org/10.1371/journal.pone.0189342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736217/
https://www.ncbi.nlm.nih.gov/pubmed/29261715
http://dx.doi.org/10.1371/journal.pone.0189342

Ejemplares similares